CVE-2026-32979
OpenClaw before 2026.3.11 contains an approval integrity vulnerability allowing attackers to execute rewritten local code by modifying scripts between approval and execution when exact file binding cannot occur.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.13%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
OpenClaw before 2026.3.11 contains an approval integrity vulnerability allowing attackers to execute rewritten local code by modifying scripts between approval and execution when exact file binding cannot occur. Remote attackers can change approved local scripts before execution to achieve unintended code execution as the OpenClaw runtime user.
- CVSS 4.0
- 7.0 HIGHCVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.13% probability · 3th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-367
- Affected
- openclaw/openclaw
- Source
- disclosure@vulncheck.com
EPSS 0.1% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.